Diabetes Drug Stops Prostate Cancer From Coming Back

Diabetes Drug Stops Prostate Cancer From Coming Back

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients with diabetes who took PPARy-targeting drugs stayed cancer-free during follow-up. The drug, pioglitazone, appears to rewire cancer cell metabolism and suppress growth. Promising Drug Discovery in Prostate Cancer In a discovery that could open new doors for [...]

Prostate Cancer Slowed by Current Diabetes Medication

New research, led by investigators at Medical University Vienna, has shown that a medication long used to manage type 2 diabetes has potential to treat prostate cancer. Results of the international effort, published in iScience, found that drugs targeting a protein known as peroxisome proliferator-activated receptor gamma (PPARγ) may reduce the likelihood of prostate cancer recurrence in patients with type 2 diabetes. “This is a significant disc…